ICMR partners with Bharat Biotech, aims to launch indigenous
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The Indian Council of Medical Research (ICMR) on Thursday (July 2) partnered with Bharat Biotech International Limited (BBIL) to fast-track clinical trials of the indigenous COVID-19 vaccine (BBV152 COVID Vaccine).

In an official statement, ICMR Director General Balram Bhargava stated that ICMR aims to launch the indigenous COVID-19 vaccine by August 15.

The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune.

ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine.

12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine and ensure that the subject enrolment is initiated during the first week of July.

Source: https://www.businessinsider.in/india/news/icmr-selects-12-institutes-for-clinical-trial-of-covid-19-vaccine/articleshow/76758692.cms
Dr. T●●●●z H●●●●●●i and 27 others like this24 shares
Like
Comment
Share